US Patent Issued to Ranok Therapeutics (Hangzhou) on Feb. 3 for "Methods and compositions for targeted protein degradation" (American, Chinese Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,143, issued on Feb. 3, was assigned to Ranok Therapeutics (Hangzhou) Co. Ltd. (Zhejiang, China).

"Methods and compositions for targeted protein degradation" was invented by Weiwen Ying (Lexington, Mass.), Long Ye (Shanghai) and Kevin Foley (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compounds of Formula I:and pharmaceutically acceptable salts and compositions thereof, which are useful for treating cancers and related conditions."

The patent was filed on April 8, 2020, under Application No. 17/602,345.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parse...